AX20017
CAS No. 329221-38-7
AX20017 ( —— )
Catalog No. M20738 CAS No. 329221-38-7
AX20017 is a small-molecule protein kinase G (PknG) inhibitor(IC50 : 0.39 μM). It acts by blocking the proliferation of M. tuberculosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 39 | In Stock |
|
5MG | 59 | In Stock |
|
10MG | 83 | In Stock |
|
25MG | 178 | In Stock |
|
50MG | 309 | In Stock |
|
100MG | 464 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAX20017
-
NoteResearch use only not for human use.
-
Brief DescriptionAX20017 is a small-molecule protein kinase G (PknG) inhibitor(IC50 : 0.39 μM). It acts by blocking the proliferation of M. tuberculosis.
-
DescriptionAX20017 is a small-molecule protein kinase G (PknG) inhibitor(IC50 : 0.39 μM). It acts by blocking the proliferation of M. tuberculosis.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPknG
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number329221-38-7
-
Formula Weight264.34
-
Molecular FormulaC13H16N2O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:32 mg/mL (121.06 mM)
-
SMILESNC(=O)c1c(NC(=O)C2CC2)sc2CCCCc12
-
Chemical Name2-(Cyclopropanecarbonylamino)-233a45677a-octahydro-1-benzothiophene-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Scherr N Honnappa S Kunz G et al. Structural basis for the specific inhibition of protein kinase G a virulence factor of Mycobacterium tuberculosis[J]. Proceedings of the National Academy of Sciences 2007 104(29):12151-12156.
molnova catalog
related products
-
4-O-Cinnamoylquinic ...
4-O-Cinnamoylquinic acid is a natural product for research related to life sciences.
-
ML188
ML188 is a selective noncovalent SARS-CoV 3CLpro inhibitor(IC50 : 1.5 μM), with moderate MW and good enzyme and antiviral inhibitory activity.
-
Apraglutide TFA (129...
Apraglutide TFA (FE 203799 TFA), a synthetic 33-amino-acid peptide and a long-acting GLP-2 analogue, enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum.